Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


New Health Affairs Series on Drug Pricing

Medicare prescription drug problem offers solution to health insurance marketplaces

A new series of Health Affairs health policy briefs, published with support from The Commonwealth Fund and Memorial Sloan Kettering’s Drug Pricing Lab, focuses on four of the key issues affecting prescription drug prices in the U.S.: expedited approval pathways, "orphan" drugs, biosimilar drugs, and patent settlements.

Publication Details